Literature DB >> 23580771

Making things stick in the fight against atherosclerosis.

Ira Tabas1.   

Abstract

Entities:  

Year:  2013        PMID： 23580771      PMCID： PMC3662540          DOI： 10.1161/CIRCRESAHA.113.301227

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  19 in total

Review 1.  Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.

Authors:  C N Serhan; N Chiang
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 2.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis.

Authors:  Mark E Lobatto; Valentin Fuster; Zahi A Fayad; Willem J M Mulder
Journal:  Nat Rev Drug Discov       Date:  2011-10-21       Impact factor: 84.694

Review 3.  Molecular imaging in atherosclerosis: FDG PET.

Authors:  David Rosenbaum; Antoine Millon; Zahi A Fayad
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 4.  Vulnerable plaque: the pathology of unstable coronary lesions.

Authors:  Renu Virmani; Allen P Burke; Frank D Kolodgie; Andrew Farb
Journal:  J Interv Cardiol       Date:  2002-12       Impact factor: 2.279

Review 5.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

6.  Painting blood vessels and atherosclerotic plaques with an adhesive drug depot.

Authors:  Christian J Kastrup; Matthias Nahrendorf; Jose Luiz Figueiredo; Haeshin Lee; Swetha Kambhampati; Timothy Lee; Seung-Woo Cho; Rostic Gorbatov; Yoshiko Iwamoto; Tram T Dang; Partha Dutta; Ju Hun Yeon; Hao Cheng; Christopher D Pritchard; Arturo J Vegas; Cory D Siegel; Samantha MacDougall; Michael Okonkwo; Anh Thai; James R Stone; Arthur J Coury; Ralph Weissleder; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-11       Impact factor: 11.205

Review 7.  Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions.

Authors:  Jerome L Fleg; Gregg W Stone; Zahi A Fayad; Juan F Granada; Thomas S Hatsukami; Frank D Kolodgie; Jacques Ohayon; Roderic Pettigrew; Marc S Sabatine; Guillermo J Tearney; Sergio Waxman; Michael J Domanski; Pothur R Srinivas; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2012-09

Review 8.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

9.  Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.

Authors:  Nazila Kamaly; Gabrielle Fredman; Manikandan Subramanian; Suresh Gadde; Aleksandar Pesic; Louis Cheung; Zahi Adel Fayad; Robert Langer; Ira Tabas; Omid Cameron Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

10.  Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Víctor Brito; Katia Mellal; Simon Giroux Portelance; Arlenis Pérez; Yosdel Soto; Denis deBlois; Huy Ong; Sylvie Marleau; Ana María Vázquez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-18       Impact factor: 8.311
View more
  1 in total

1.  Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody.

Authors:  Yosdel Soto; Niurka Mesa; Yumisley Alfonso; Arlenis Pérez; Fernando Batlle; Tania Griñán; Adonis Pino; Justo Viera; Milagros Frómeta; Victor Brito; Armando Olivera; Francisco Zayas; Ana M Vázquez
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.